Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
0.6676
-0.0022 (-0.33%)
At close: Apr 2, 2025, 4:00 PM
0.6688
+0.0012 (0.18%)
After-hours: Apr 2, 2025, 7:50 PM EDT

Palisade Bio Market Cap

Palisade Bio has a market cap or net worth of $2.94 million as of April 2, 2025. Its market cap has decreased by -11.05% in one year.

Market Cap
2.94M
Enterprise Value
-6.73M
1-Year Change
-11.05%
Ranking
Category
Stock Price
$0.67

Market Cap Chart

Created with Highcharts 11.4.8Range1 Month1M6 Months6MYear to DateYTD1 Year1Y3 Years3Y5 Years5Y10 Years10YFull HistoryMax30 Mar 20071 Apr 2025Max ▾2008200920102011201220132014201520162017201820192020202120222023202420250100M200M300M400M3M

Since March 30, 2007, Palisade Bio's market cap has decreased from $82.40M to $2.94M, a decrease of -96.44%. That is a compound annual growth rate of -16.90%.

History

DateMarket Cap% Change
Apr 1, 20252.90M31.82%
Dec 31, 20242.20M-59.26%
Dec 29, 20235.40M-32.50%
Dec 30, 20228.00M-54.55%
Dec 31, 202117.60M15.79%
Dec 31, 202015.20M300.00%
Dec 31, 20193.80M-33.33%
Dec 31, 20185.70M-78.08%
Dec 29, 201726.00M-16.13%
Dec 30, 201631.00M-67.02%
Dec 31, 201594.00M-60.62%
Dec 31, 2014238.70M6.23%
Dec 31, 2013224.70M203.65%
Dec 31, 201274.00M55.14%
Dec 30, 201147.70M-51.92%
Dec 31, 201099.20M57.96%
Dec 31, 200962.80M20.54%
Dec 31, 200852.10M-54.10%
Dec 31, 2007113.50M37.74%
View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 734.75B
UnitedHealth Group 478.58B
Johnson & Johnson 374.39B
AbbVie 362.98B
Novo Nordisk 301.38B
Abbott Laboratories 228.81B
AstraZeneca 225.76B
Merck & Co. 218.75B
Market Cap Rankings